Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Pain | |||||
Systematic review |
53 women with primary dysmenorrhoea 2 RCTs in this analysis |
Pain relief, as measured by subjective assessment
30/53 (57%) with high-frequency TENS 8/53 (15%) with placebo TENS |
OR 7.2 95% CI 3.1 to 16.5 |
Large effect size | high-frequency TENS |
RCT Crossover design |
26 women with primary dysmenorrhoea |
Change in visual analogue scale pain score
after treatment
From 4.81 to 2.18 with TENS for 1 cycle From 4.44 to 3.07 with sham TENS for 1 cycle |
P = 0.018 |
Effect size not calculated | TENS |
Need for additional medication | |||||
Systematic review |
32 women with primary dysmenorrhoea Data from 1 RCT |
Proportion of women needing additional analgesics
22/32 (69%) with high-frequency TENS 28/32 (88%) with placebo TENS |
OR 0.3 95% CI 0.1 to 1.1 |
Not significant | |
Systematic review |
24 women with primary dysmenorrhoea Data from 1 RCT |
Mean number of analgesic tablets taken each day
6.92 with high-frequency TENS 6.78 with placebo TENS |
WMD +0.1 tablets 95% CI –2.1 tablets to +2.4 tablets Randomisation and blinding unclear |
Not significant |